Activation of Melanocortin Receptors MC₁ and MC₅ Attenuates Retinal Damage in Experimental Diabetic Retinopathy

Figure 9

Array of cytokines and chemokines released in the retina of diabetic mice. A specific ELISA kit was used in order to quantify the levels of cytokines and chemokines after 16 weeks of diabetes in mice treated or not with the melanocortin receptor agonists/antagonists as in Figure 8. The values represent the mean ± SEM of 8–10 mice per group. Significant differences against nondiabetic mice are expressed as ; significant differences versus diabetic are expressed as .